Nomura Holdings Inc. decreased its position in shares of Cerner Co. (NASDAQ:CERN) by 52.8% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,861 shares of the company’s stock after selling 15,502 shares during the period. Nomura Holdings Inc.’s holdings in Cerner were worth $829,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Parnassus Investments CA raised its position in Cerner by 178.1% in the 2nd quarter. Parnassus Investments CA now owns 7,207,631 shares of the company’s stock valued at $430,944,000 after purchasing an additional 4,616,290 shares in the last quarter. Summit Trail Advisors LLC raised its position in Cerner by 5,166.1% in the 1st quarter. Summit Trail Advisors LLC now owns 1,980,457 shares of the company’s stock valued at $1,980,000 after purchasing an additional 1,942,849 shares in the last quarter. Loomis Sayles & Co. L P raised its position in Cerner by 18.0% in the 1st quarter. Loomis Sayles & Co. L P now owns 12,297,860 shares of the company’s stock valued at $713,276,000 after purchasing an additional 1,877,563 shares in the last quarter. Epoch Investment Partners Inc. raised its position in Cerner by 1,497.5% in the 2nd quarter. Epoch Investment Partners Inc. now owns 1,520,499 shares of the company’s stock valued at $90,910,000 after purchasing an additional 1,425,317 shares in the last quarter. Finally, Old Mutual Global Investors UK Ltd. acquired a new stake in Cerner in the 1st quarter valued at about $62,557,000. 76.03% of the stock is currently owned by hedge funds and other institutional investors.
CERN has been the topic of a number of analyst reports. Piper Jaffray Companies reaffirmed a “buy” rating and issued a $71.00 price target on shares of Cerner in a research report on Friday, August 3rd. Canaccord Genuity increased their price target on Cerner from $64.00 to $71.00 and gave the company a “buy” rating in a research report on Friday, August 3rd. Royal Bank of Canada reaffirmed a “buy” rating and issued a $72.00 price target on shares of Cerner in a research report on Friday, August 3rd. Wells Fargo & Co set a $73.00 price target on Cerner and gave the company a “buy” rating in a research report on Wednesday, June 6th. Finally, Jefferies Financial Group set a $70.00 price target on Cerner and gave the company a “buy” rating in a research report on Friday, June 1st. Two investment analysts have rated the stock with a sell rating, eight have issued a hold rating and eleven have assigned a buy rating to the company. The company has an average rating of “Hold” and an average target price of $71.71.
Cerner (NASDAQ:CERN) last issued its earnings results on Thursday, August 2nd. The company reported $0.62 earnings per share for the quarter, topping the consensus estimate of $0.60 by $0.02. Cerner had a return on equity of 15.26% and a net margin of 16.06%. The business had revenue of $1.37 billion for the quarter, compared to analyst estimates of $1.33 billion. During the same quarter last year, the company earned $0.61 EPS. The business’s quarterly revenue was up 5.9% on a year-over-year basis. equities analysts forecast that Cerner Co. will post 2.28 EPS for the current year.
In related news, Director Linda M. Dillman sold 3,900 shares of the firm’s stock in a transaction that occurred on Monday, August 6th. The stock was sold at an average price of $66.54, for a total transaction of $259,506.00. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CAO Michael R. Battaglioli sold 4,000 shares of the firm’s stock in a transaction that occurred on Monday, August 6th. The stock was sold at an average price of $67.02, for a total value of $268,080.00. Following the transaction, the chief accounting officer now owns 2,226 shares in the company, valued at approximately $149,186.52. The disclosure for this sale can be found here. Insiders have sold a total of 1,270,870 shares of company stock worth $82,486,031 in the last three months. Corporate insiders own 4.71% of the company’s stock.
Cerner Corporation provides health care information technology solutions and services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.
Want to see what other hedge funds are holding CERN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cerner Co. (NASDAQ:CERN).
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.